PCV55 THIRY-DAY RESOURCE USE DIARY DATA FROM THE BURST STUDY  by Seung, SJ et al.
expected to be neutral, given equivalent unit prices with ARBs.
Most results were robust to changes in underlying model settings
and parameters, and in the range of acceptable values for health
care interventions. CONCLUSION: Compared to several stan-
dard antihypertensives, aliskiren provides good value for money,
and in some cases, results in cost savings and better outcomes.
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OBJECTIVE: This study identiﬁes 30-day post discharge direct
medical and nonmedical resources of ischemic stroke patients
who are participants from The BURden of Ischemic STroke
(BURST) Study. METHODS: The BURST Study is a prospective,
observational study with a cohort (N = 200) of ischemic stroke
patients recruited in a consecutive manner at stroke sites
(N = 10) across Canada. In addition to four questionnaires,
study participants were asked to complete a 30-day diary after
discharge evaluating physician and health professional visits
(direct medical) as well as paid services and purchase of stroke-
related items (direct nonmedical). RESULTS: A total of 61
diaries were analyzed. Demographics included mean age
62.7  15.5 (27–93) years, 52.4% male and 72.1% discharged
as outpatients. On average, 4.8  5.9 (0–28) doctor visits were
reported. Inpatients at rehabilitation and long term care facilities
had a mean 10.2  8.4 (1–28) visits compared to 2.9  3.0
(0–12) by outpatients. Nurses, therapists (physiotherapy, occu-
pational and speech), social workers and dieticians were the
most visited health professionals by all patients with a mean
20.1  29.3 (0–98) visits. Inpatients reported more visits with a
mean 59.2  25.8 (3–98) visits compared to 4.9  10.4 (0–52)
by outpatients. Seventeen patients reported an average
10.5  10.1 (1–30) paid service visits while 19 patients pur-
chased at least one stroke-related item under $499. CONCLU-
SION: Patients reported an average 5 doctor visits and 20 health
professional visits, 30 days following their ﬁrst ischemic stroke.
The average number of visits increased if patients were dis-
charged to an inpatient facility. Approximately 30% patients
paid for services (e.g. housekeeping or transportation) and also
purchased stroke- related items (e.g. cane or home renovations).
The next step will be to apply unit costs to this data for cost
calculations.
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OBJECTIVE: Cardiovascular x-ray imaging machines have
advanced patient care by providing the latest in imaging technol-
ogy for diagnostic and interventional purposes. Hospitals are
faced with the ﬁnancial dilemma of whether the beneﬁts of
purchasing such a machine outweigh the costs. One important
economic driver to help them make the decision is current and
potential procedural mix and utilization data. However, limited
research exists in this area and hospitals may not have access to
this type of information. Therefore the objective of this analysis
was to assess the volume and mix of cardiac x-ray procedures
across U.S. hospitals so hospitals can utilize this data to make
informed ﬁnancial decisions. METHODS: A cross-sectional ret-
rospective analysis of hospital claims for the 2005 calendar year
was conducted using the Premier’s Comparative Database(tm).
Procedures of interest were identiﬁed via primary and secondary
ICD-9 procedure codes. Average volume per hospital was calcu-
lated as the total number of procedures of interest divided by the
number of hospitals that conducted at least one procedure of
interest. Procedure volume data was then rolled up into three
speciﬁc categories: coronary/cardiac, peripheral and electro-
physiology. RESULTS: In one year, a hospital on average con-
ducted 3144 cardiac x-ray imaging procedures. A majority
(48.1%) of the procedures were coronary/cardiac (N = 1512),
followed by peripheral procedures at 36.9% (N = 1161) and the
ﬁnal 15.0% were electrophysiology procedures (N = 471). CON-
CLUSION: Results of this analysis could help hospitals develop
cost-beneﬁt models which can assist them in making ﬁnancial
decisions regarding purchasing a cardiology x-ray imaging
machine.
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OBJECTIVE: To estimate the proportion of a population
underutilizing previously initiated therapy with statins and/or
angiotensin converting enzyme inhibitors or angiotensin-II recep-
tor blockers (ACEi/A2RB) and, of these, percent with high car-
diovascular risk and how well they are identiﬁed by a strategy
that targets new users. METHODS: The study sample consists of
a geographically deﬁned subset of a commercially insured popu-
lation who were age 25 to 84 on October 31, 2007 and continu-
ously enrolled from January 2002 through November 2007. For
all patients with any history of ﬁlling a prescription in the respec-
tive drug category January 2002 to June 2006, the proportion of
days covered (PDC) July 2006 to June 2007 is deduced from
dispensed dates and days supplied. Underutilization is deﬁned as
PDC 0% or >0%–<80%. Claims January 2002–June 2006 are
assessed for high cardiovascular risk criteria including: acute
myocardial infarction, coronary revascularization, coronary ath-
erosclerosis, acute ischemic stroke, diabetes, peripheral arterial
disease, abdominal aortic aneurysm, nitrates, platelet aggrega-
tion inhibitors, diabetes therapy, cilastazol or pentoxyphylline.
RESULTS: Of 294,734 in the sample, 70,814 (24.0%) ﬁlled >=1
prescription for a statin and 65361 (22.2%) for an ACEi/A2RB
between 2002 and June 2006. During the subsequent 12 months,
PDC was 0% and >0–<80%, respectively, for: 19.1% and 34.5%
of all patients with previous statin history, 16.2% and 33.1% of
those satisfying risk criteria; 26.7% and 26.7% of all with pre-
vious ACEi/A2RB history, 25.6% and 26.7% of those satisfying
risk criteria. Patients who were new users in preceding 12 months
(July 2005–June 2006) comprised 10.9% of high risk patients
underutilizing previously started statin therapy and 7.6% of
those underutilizing previously started ACEi/A2RB therapy.
CONCLUSION: Underutilization of cardiovascular risk-
lowering medications is an important problem that requires
strategies beyond targeting new users.
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